Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

AI-Guided Cardiac Ablation in combination with pulmonary vein isolation was superior to the standard of care in the treatment of Persistent ...

Study Reveals Why Newborns Can Regenerate Heart Tissue While Adults Struggle After a Heart AttackA new study in experimental animals reveals a ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

The last two decades have seen an increase in the use of biological over mechanical heart valve replacements. However, while ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

This year’s American Heart Association Go Red for Women Red Dress Collection Concert saw iconic stars join forces to advocate ...

Every year, more than 5 million people in the U.S. are diagnosed with heart valve disease, but this condition has no ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

Investors remain bullish on medical device makers, expecting them to benefit from still-high demand for surgical procedures, ...